Lilly: Weight-Loss Drug Demand May Outpace Supply

Published on January 8, 2024

Eli Lilly CEO David Ricks on Monday said the company’s powerful weight-loss drug Zepbound hit 25,000 new prescriptions per week at the end of December, and that its 2024 supply may not be enough to meet demand. “I think it’s important to set expectations, but we’re working…

Read Full Article (External Site)